Muluneh B[au] - Search Results

Year	Number of Results
2010	1
2011	2
2012	2
2013	2
2014	1
2016	2
2017	3
2018	6
2019	9
2020	7
2021	9
2022	15
2023	2

1

Muluneh B. Muluneh B. J Clin Oncol. 2022 Jan 10;40(2):213-214. doi: 10.1200/JCO.21.01909. Epub 2021 Oct 14. J Clin Oncol. 2022. PMID: 34648355 No abstract available.

2

Oral oncolytic treatment for chronic lymphocytic leukemia.

Harris V, Borlagdan J, Muluneh B. Harris V, et al. Among authors: muluneh b. J Oncol Pharm Pract. 2022 Jun;28(4):935-944. doi: 10.1177/10781552211073906. Epub 2022 Jan 27. J Oncol Pharm Pract. 2022. PMID: 35084245 Review.

3

Pharmacists' Role in Managing Patients with Chronic Lymphocytic Leukemia.

Chen KY, Brunk KM, Patel BA, Stocker KJ, Auten JJ, Buhlinger KM, Muluneh B. Chen KY, et al. Among authors: muluneh b. Pharmacy (Basel). 2020 Mar 27;8(2):52. doi: 10.3390/pharmacy8020052. Pharmacy (Basel). 2020. PMID: 32230834 Free PMC article. Review.

4

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.

Belcher SM, Mackler E, Muluneh B, Ginex PK, Anderson MK, Bettencourt E, DasGupta RK, Elliott J, Hall E, Karlin M, Kostoff D, Marshall VK, Millisor VE, Molnar M, Schneider SM, Tipton J, Yackzan S, LeFebvre KB, Sivakumaran K, Waseem H, Morgan RL. Belcher SM, et al. Among authors: muluneh b. Oncol Nurs Forum. 2022 Jun 17;49(4):279-295. doi: 10.1188/22.ONF.279-295. Oncol Nurs Forum. 2022. PMID: 35788731 Free PMC article.

5

Online Pharmacy Accessibility of Imatinib, An Oral Chemotherapy Medication.

Sun Y, Hendrix A, Muluneh B, Ozawa S. Sun Y, et al. Among authors: muluneh b. J Natl Compr Canc Netw. 2022 Jul;20(7):808-814. doi: 10.6004/jnccn.2022.7007. J Natl Compr Canc Netw. 2022. PMID: 35830891

6

Enhancing the Design and Evaluation of Care Delivery for Patients on Oral Anticancer Agents.

Muluneh B. Muluneh B. J Natl Compr Canc Netw. 2022 Oct;20(10):1185-1187. doi: 10.6004/jnccn.2022.7076. J Natl Compr Canc Netw. 2022. PMID: 36240843 No abstract available.

7

Outpatient initiation of venetoclax in patients with acute myeloid leukemia.

Palmer S, Patel A, Wang C, Patel B, Zeidner J, Foster M, Muluneh B, Buhlinger K. Palmer S, et al. Among authors: muluneh b. J Oncol Pharm Pract. 2022 Dec 6:10781552221142872. doi: 10.1177/10781552221142872. Online ahead of print. J Oncol Pharm Pract. 2022. PMID: 36474407

8

Evaluation of an interdisciplinary venetoclax initiation process in minimizing risk of tumor lysis syndrome.

Cozad M, Stump SE, Buhlinger K, Collins J 4th, Muir M, Coombs CC, Muluneh B. Cozad M, et al. Among authors: muluneh b. Leuk Lymphoma. 2022 Aug;63(8):1831-1838. doi: 10.1080/10428194.2022.2047963. Epub 2022 Mar 9. Leuk Lymphoma. 2022. PMID: 35262457

9

Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics.

Palmer S, Chen A, Dennison T, Czech C, Auten J, Buhlinger K, Muluneh B. Palmer S, et al. Among authors: muluneh b. Pharmacy (Basel). 2021 Jul 23;9(3):130. doi: 10.3390/pharmacy9030130. Pharmacy (Basel). 2021. PMID: 34449698 Free PMC article. Review.

10

Financial Toxicity in Patients With Cancer: What a Tangled Web We Weave.

Muluneh B. Muluneh B. J Natl Compr Canc Netw. 2021 Jan 6;19(1):3-5. doi: 10.6004/jnccn.2020.7649. J Natl Compr Canc Netw. 2021. PMID: 33406494 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results